# U.S. Stem Cell, Inc. (USRM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/USRM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 91.7K | $ -3.19M | $ -340.6K | $ 8.95M | $ -14.75M |
| 2021 | $ 238.6K | $ -3.91M | $ -1.26M | $ 8.02M | $ -12.77M |
| 2020 | $ 353.0K | $ -3.68M | $ -610.1K | $ 7.48M | $ -11.58M |
| 2019 | $ 3.97M | $ -4.95M | $ -1.56M | $ 6.18M | $ -9.48M |
| 2018 | $ 8.85M | $ -2.85M | $ 795.7K | $ 5.05M | $ -6.88M |
| 2017 | $ 7.44M | $ -4.69M | $ 1.66M | $ 5.16M | $ -7.10M |
| 2016 | $ 4.24M | $ -2.85M | $ 137.1K | $ 5.19M | $ -8.02M |
| 2015 | $ 3.08M | $ -2.31M | $ -1.19M | $ 4.65M | $ -7.72M |
| 2014 | $ 2.77M | $ -3.18M | $ -1.58M | $ 5.36M | $ -10.89M |
| 2013 | $ 171.3K | $ -4.47M | $ -2.73M | $ 5.67M | $ -13.75M |
| 2012 | $ 88.2K | $ -5.80M | $ -1.58M | $ 5.87M | $ -14.60M |
| 2011 | $ 25.7K | $ -6.90M | $ -2.49M | $ 3.23M | $ -12.01M |
| 2010 | $ 105.2K | $ -6.32M | $ -2.87M | $ 5.99M | $ -12.02M |
| 2009 | $ 544.8K | $ -6.03M | $ -3.07M | $ 8.09M | $ -13.41M |
| 2008 | $ -29.4K | $ -21.51M | $ -16.63M | $ 8.94M | $ -14.24M |
| 2007 | $ 473.6K | $ -27.36M | $ -8.43M | $ 9.61M | $ -5.50M |
| 2006 | $ 159.7K | $ -19.96M | N/A | $ 0 | $ 4.31M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.61 |
| Liabilities / Eq | -1.00 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/USRM.md)
- [Charts](https://sponda.capital/en/USRM/charts.md)
- [Compare](https://sponda.capital/en/USRM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.